Enocitabine

依诺他滨

Also known as: BH-AC, N4-Behenoylcytosine arabinoside, Behenoylcytosine arabinoside, Sunrabin, NSC-239336, N-(1-β-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)docosanamide, 1-(β-D-Arabinofuranosyl)-4-(docosanoylamino)-2(1H)-pyrimidinone, 1-(β-D-Arabinofuranosyl)-4-(docosanoylamino)pyrimidin-2(1H)-one, 2(1H)-Pyrimidinone, 1-β-D-arabinofuranosyl-4-[(1-oxodocosyl)amino]-, Docosanamide, N-(1-β-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, Enocitabine [INN:JAN], MFCD00866294

Enocitabine (CAS 55726-47-1) is a compound in the Organic Compounds category listed in the Jingsj chemical database. It has the molecular formula C31H55N3O6 and a molecular weight of 565.785 g/mol. It is also known as BH-AC, N4-Behenoylcytosine arabinoside and Behenoylcytosine arabinoside. Key properties include a melting point of 141-142ºC and a density of 1.2±0.1 g/cm3. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 55726-47-1
Jingsj CID: J-1980003-1
Molecular Formula: C₃₁H₅₅N₃O₆
Chinese Name: 依诺他滨
Molecular Weight: 565.785 g/mol
Category: Organic Compounds
Last updated: 8/21/2026

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	141-142ºC
Density	1.2±0.1 g/cm3
Exact Mass	565.409058
PSA	133.91000
LogP	9.00
Refractive Index	1.554
Storage Conditions	-20°C Freezer

Activity & Biological Data

Target	DNA replication[1]; CMV[3]
Additional Information	[1]. Hamada A, et al. Clinical pharmacokinetics of cytarabine formulations.Clin Pharmacokinet. 2002;41(10):705-18. [2]. Nagasawa M, et al.In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines. Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 1):633-8. [3]. Nakamura K, et al. Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus. J Med Virol. 1990 Jun;31(2):141-7.

Target

DNA replication[1]; CMV[3]

Additional Information

[1]. Hamada A, et al. Clinical pharmacokinetics of cytarabine formulations.Clin Pharmacokinet. 2002;41(10):705-18. [2]. Nagasawa M, et al.In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines. Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 1):633-8. [3]. Nakamura K, et al. Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus. J Med Virol. 1990 Jun;31(2):141-7.

Frequently Asked Questions

What is the CAS number of Enocitabine?

The CAS number of Enocitabine is 55726-47-1.

What are the molecular formula and molecular weight of Enocitabine?

Enocitabine has molecular formula C31H55N3O6 and molecular weight 565.785 g/mol.

Data compiled from public chemical databases and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Enocitabine (CAS 55726-47-1)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1980003-1 (accessed 2026-10-28).

Data for reference only; verify specifications, grades and regulatory status with suppliers before purchase.